| Title: |
Pathways to Precision. |
| Authors: |
Cecchini, Matthew J.1 Matthew.Cecchini@lhsc.on.ca |
| Source: |
Archives of Pathology & Laboratory Medicine. Jul2024, Vol. 148 Issue 7, p754-756. 3p. |
| Subject Terms: |
*MEDICAL protocols, *SERIAL publications, *PROGRAMMED death-ligand 1, *IMMUNOTHERAPY, *CANCER patients, *TUMOR markers, *DECISION making in clinical medicine, *IMMUNOHISTOCHEMISTRY, *IMMUNE checkpoint inhibitors, *LUNG tumors, *INDIVIDUALIZED medicine, *GENETIC mutation, *GENETIC testing |
| Abstract: |
The author discusses a comprehensive guideline on programmed death ligand-1 ( PD-L1) and tumor mutation burden (TMB) testing in lung cancer released by a collaborative group in the issue. Topics include recommendations for the use of PD-L1 and TMB testing in lung cancer to direct the selection of patients for immunotherapy, the evolution of the landscape of PD-L1 testing, and the use of TPS in lung cancer. |
| Database: |
Academic Search Complete |
